Subscribe to Newsletter

Search

Reset Filter

4233 search results for ‘*’

Discovery & Development Drug Delivery

Squid-Inspired Drug Delivery

| Stephanie Vine | 4 min read

Here’s how researchers took lessons from cephalopods to develop a new capsule that can deliver drugs, including insulin and siRNA, orally.

Manufacture Advanced Medicine

The Next Decade of Cell and Gene Therapies

| 5 min read

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems; we ask experts about the future of advanced medicine.

Discovery & Development Drug Discovery

Antibiotics: Going With the Flow

| Rob Coker | 2 min read

How fluid flow through the body can affect the ways in which antibiotics work.

Business & Regulation Business Practice

The Trump Effect on Cell and Gene: Science versus Shockwaves

| 9 min read

Audrey Greenberg on FDA staffing cuts, Peter Marks’ resignation, CDMO pressure, IP migration, AI acceleration, and what CGT needs now to stay on track

Business & Regulation Standards & Regulation

Peter Marks Resigns from FDA

| Stephanie Vine | 3 min read

Resignation letter states: “truth and transparency” around vaccines are not desired by Health Secretary RJK Jr.

Business & Regulation Standards & Regulation

Vaccines and Autism: Perpetuating a Populist Agenda

| Rob Coker | 3 min read

Rumours claim that a well-known vaccine skeptic has been appointed to lead study on links between vaccines and autism.

Business & Regulation Digital Technologies

AI, Big Data, and Digital Disruption

| Rob Ellison | 7 min read

An industry survey looks at changing attitudes and challenges in digital innovation for clinical research. Uptake is slow but steady.

Discovery & Development Drug Discovery

The Glycomic Revolution

| 2 min read

Why the ability to design therapeutics based on glycobiology will make a mark on pharma R&D.

Business & Regulation Standards & Regulation

The Future of the NIH

| Hernan Bazan | 2 min read

Thoughts on the US National Institutes of Health and its role in funding research for non-opioid therapeutics.

Manufacture Advanced Medicine

Building a Resilient CGT Workforce

| Daniel Palmacci | 3 min read

With competition for skilled employees in cell and gene therapy manufacturing high, companies need to invest in training and mentorship.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register